the announcement also leads me to assume that the deal is still active.
good point.. that alone is reason enough for a news release. If ChinaCo was walking away they would not be proceeding with the study. Also, there were some interesting assay values released in the PR that no one has bothered mentioning around here
Yes that is surely part of the equation. Although I don't think any knowledgeable investor had any reason to believe the deal had become inactive?
If it had become inactive one would hope that the exclusivity could be ended earlier and SRSR could move on to the next potential partner.
In an efficient market the price certainly would be rising, however its isn't efficient and SRSR is not attracting new buyers despite the opportunity, so I still expect the price to retreat until there is a catalyst to bring in new investors.
Once we see some real volume sustained that will indicate some successful deal probability.